Download PDF

Other users also viewed these articles

Clinical complications in children with false-negative results in cystic fibrosis newborn screening Katarzyna Zybert; Urszula Borawska-Kowalczyk; Lukasz Wozniacki; Malwina Dawidziuk; Mariusz O¿tarzewski; Dorota Sands;
J Pediatr (Rio J). 2022;98:419-24
Efficacy and safety of using ELEXACAFTOR/Tezacaftor/Ivacaftor in the treatment of children with cystic fibrosis: real-world evidence from Brazil Guilherme da Silva Martins; Carolina Rambo; Gabriela Spessatto; Maitê Milagres Saab; Bruno Hernandes David João; Aline Didoni Fajardo; Juliana Gonçalves Primon; Thalita Gonçalves Picciani; Roberta Corrêa da Cunha; Herberto José Chong-Neto; Carlos Roberto Lebarbenchon Massignan; Luiz Vicente Ribeiro Ferreira da Silva Filho; Carlos Antônio Riedi; Nelson Augusto Rosário Filho; Débora Carla Chong-Silva;
10.1016/j.jped.2025.05.007
The newborn screening tests in Brazil: regional and socioeconomic prevalence and inequalities in 2013 and 2019 Letícia R. Dias; Yaná T. Tomasi; Antonio F. Boing;
J Pediatr (Rio J). 2024;100:296-304